Le Lézard
Classified in: Business
Subject: DIVIDENDS

Dream Office REIT April 2017 Monthly Distribution


TORONTO, ONTARIO--(Marketwired - April 19, 2017) - DREAM OFFICE REIT (TSX:D.UN) today announced its April 2017 monthly distribution of 12.500 cents per REIT Unit, Series A ($1.50 annualized). The April distribution will be payable on May 15, 2017 to unitholders of record as at April 28, 2017.

Dream Office REIT is an unincorporated, open-ended real estate investment trust. Dream Office REIT is focused on owning, acquiring, leasing and managing well-located, high-quality central business district and suburban office properties. Its portfolio currently comprises approximately 17.2 million square feet of gross leasable area in major urban centres across Canada. Dream Office REIT's portfolio is well diversified by geographic location and tenant mix. For more information, please visit www.dreamofficereit.ca.


These press releases may also interest you

at 12:47
A new integration between Procare Solutions, a leader in child care management software for more than 30 years, and IntelliKid Systems, a leading provider of child care enrollment and marketing software, offers a suite of marketing tools to connect...

at 12:45
Fifth Avenue Financial, a premier financial services company based in New York City, is excited to announce the appointment of Steven Randall CLU®, ChFC® as its newest Managing Director. A seasoned veteran in the financial services industry, Steve...

at 12:40
United® Real Estate is pleased to announce the promotion of Leigh Ann Bogran to the position of Vice President of Operations. Bogran has been a tremendous asset to United since joining its operations team two years ago as Director, Strategic Project...

at 12:40
BalancedComp, an industry-leading provider of compensation consulting and software solutions for U.S. financial institutions, is thrilled to announce the return of its esteemed event, FinComp, taking place on September 29 - October 2, 2024 at...

at 12:40
Universal Music Group N.V. ("UMG" or "the Company") today announced the results of its Annual General Meeting of Shareholders ("AGM") held earlier today....

at 12:35
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and...



News published on and distributed by: